Researchers at CU Anschutz are studying the effect of psychedelic mushrooms on patients with treatment-resistant depression.

Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

A trial for psilocybin therapy to treat depression is being opened to Vancouver Island applicants. Psilocybin is a ...

Ruby Jackson speaks to the psychiatrist researching the therapeutic potential of psychedelics ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

GH Research stock soars 55% in a week after the company meets the primary goal in a mid-stage depression study of its lead ...

A trial for psilocybin therapy to treat depression is being opened to applicants in the Nanaimo area. Psilocybin is a ...

A small Ireland-based firm, GH Research, has announced positive results from a small trial it conducted to treat treatment-resistant depression. The ...

In people with treatment-resistant depression, investigational inhalable mebufotenin yielded a 15.5-point placebo-adjusted ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...